Ana Belén Blanca

Dedicated professional with over 25 years of diverse experience in the pharmaceutical industry, encompassing roles in GSO, Medical Affairs, and the Value, Access & Policy Team. Expertise in navigating the complexities of clinical development and pricing approval processes facilitates the development and execution of strategic initiatives that align healthcare policies and regulations with organizational objectives. Proven success in building and maintaining relationships with key government officials, policymakers, and patient organizations to ensure timely access to new products. A strong track record of leading high-performance teams within the Oncology Business Unit has resulted in successful product launches in Spain, significantly contributing to company growth and success.

• Responsibilities and task in current position as VALUE & ACCESS Sr. Mgr.
• Leading pricing and reimbursement negotiation process with Director of Pharmacy & CIMP members at national level:
• - Developing product dossiers and economic models for pricing and reimbursement negotiations at national and/or regional level.
• - Developing access materials for field teams and for negotiation process.
• - Training to access teams to support new launches & in line products.
• Leading product launches at national and regional from Access Team.
• Defining and implementing access projects to speed up access after launch.
• Supporting and close collaboration with Global ACCESS teams in defining access strategy for pipeline products.
• Support HEOR teams to develop HE studies for pipeline and in-line products.
• Close collaboration with Policy & Corporate Affairs Lead:
• - by co-developing and co-executing Government Affairs strategy
• - identifying and monitoring institutions and initiatives on key policy issues and legislation (currently with focus in EU HTA Joint Clinical Assessment)
• - building alliances and expanding networks focused on reinforcing Evidence Based Policy approaches with key political stakeholders within government institutions and other organizations.
• - cross-functional alignment with the key functions (BUs, Public Affairs, Medical, Regulatory, Finance...) on identifying challenges and implementing projects.
• Focus on early engagement with key access stakeholders, especially key payors in regional governments, policy makers and Patients Advocacy groups.
• - Strong experience in collaboration with Patient Advocate Lead
• Management of high-performance teams.